
Dakar’s Sickle Cell Breakthrough
A Senegalese pharmaceutical company, Teranga Pharma, has begun producing Drepaf, a locally made generic version of hydroxyurea, marking the first time this frontline sickle cell drug has been manufactured on African soil. It is a modest-looking achievement, tablets in 500mg and 100mg doses, launched quietly in November 2025, but its

